✦ LIBER ✦

ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity

✍ Scribed by Akiko Matsuyama-Yokono; Atsuo Tahara; Ryosuke Nakano; Yuka Someya; Itsuro Nagase; Masahiko Hayakawa; Masayuki Shibasaki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ASP4000, a novel, selective, dipeptidyl

✍ Keiko Tanaka-Amino; Kazumi Matsumoto; Yoshifumi Hatakeyama; Ichiro Shima; Shoji 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 420 KB

Pharmacological profile of ASP8497, a no

✍ Yuka Someya; Atsuo Tahara; Ryosuke Nakano; Akiko Matsuyama-Yokono; Itsuro Nagase 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 202 KB

D-420720, A novel orally active sulfonam

✍ Henry J. Tsai; Shan-Yen Chou; Shih-Hsien Chuang; Chien-Cheng Chen; Feng-Lin Hsu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]

✍ Villhauer, Edwin B.; Brinkman, John A.; Naderi, Goli B.; Burkey, Bryan F.; Dunni 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 230 KB

1-[2-[(5-Cyanopyridin-2-yl)amino]ethylam

✍ Villhauer, Edwin B.; Brinkman, John A.; Naderi, Goli B.; Dunning, Beth E.; Mango 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 59 KB

E3024, 3-but-2-ynyl-5-methyl-2-piperazin

✍ Nobuyuki Yasuda; Tadashi Nagakura; Takashi Inoue; Kazuto Yamazaki; Naruo Katsuta 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 311 KB